skip to primary navigationskip to content
 

Multiple celebrations as 2016 ends on a high for local online investment platform

last modified Jan 06, 2017 02:23 PM
SyndicateRoom see its first company exit
Multiple celebrations as 2016 ends on a high for local online investment platform

From left to right: Tom Britton (Co-founder and CTO) and Goncalo de Vasconcelos (Co-founder and CEO)

Oval, a cutting-edge medical technology company, designing and producing auto-injectors to enhance medical safety and address trypanophobia (fear of needles), has been acquired by US-based healthcare contract manufacturer SMC Ltd. Oval Medical raised £1,118,647 in August 2014 via the SyndicateRoom platform, with 40 SyndicateRoom investors contributing to this total. SMC Ltd. is acquiring Oval to build on its existing business in the drug delivery device market, paving the way to grow and to develop further Oval’s core auto-injector technology.

‘This is an incredibly proud moment for SyndicateRoom and fantastic news for the investors who chose to buy into Oval two years ago when it raised through the platform,’ said Gonçalo de Vasconcelos, CEO, SyndicateRoom. ‘It also proves the value of our unique investor-led model. All SyndicateRoom investors had access to the same class of share and the same price per share as the lead investors and both are enjoying the rewards of this acquisition fairly.’

This comes after an impressive list of accolades for SyndicateRoom. At the end of November, the company picked up two awards at the second annual Growth Investor Awards, organised by Intelligent Partnership. It was named Best Investment Platform for the second year running and also Industry Game-Changer.  Judges were impressed by ”their democratic philosophy and innovations such as their EIS fund, tie up with the London Stock Exchange to give retail investors access to IPOs and their referral arrangement with Ratesetter.”

And the awards have just kept coming. At the end of November Gonçalo de Vasconcelos was shortlisted for the Entrepreneur of the Year award at the 18th annual Amazon Growing Business Award. Created by Real Business, sponsored by Amazon and supported by the CBI, The Amazon Growing Business Awards recognise SME and entrepreneurial success. 

The company has also launched new products to enable investors to better access sophisticated investment opportunities this year. The WatchList is one such product, which offers valuable support and opportunity to private investors interested in investing in smaller AIM-quoted companies.online

 

RSS Feed Latest news

Spotlight on Mursla

Feb 03, 2019

Cancer is one of the most challenging global issues an entrepreneur could choose to tackle. But Pierre Arsène and Victor Serdio are doing just that with their company Mursla. Based at ideaSpace West, Mursla is developing a breakthrough technology for early cancer detection using liquid biopsies, offering a less invasive and more responsive approach to diagnosis, treatment and cure. To mark World Cancer Day on the 4th February, we asked Pierre to explain more about Mursla and the bold ideas and enthusiasm driving this bright company.

LESSONS FROM A FOUNDER: What's Your 2019 Startup Goal?

Jan 30, 2019

For many of us, a new year often starts with an optimistic resolution to change – join the gym, write a book, travel perhaps. But if you’re running a startup, January is a great time to assess your company’s development and set fresh goals for the coming year. We asked four founders at ideaSpace to reflect on progress and share their area of focus for 2019.

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

A Breath Test Could Detect Early Cancer Signs

Jan 06, 2019

CRUK and ideaSpace City members, Owlstone Medical, have launched a new trial to discover whether it's possible to detect early stage cancer symptoms from a person's breath.

Petagene secure $2.1 Million in Funding 

Jan 03, 2019

2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

View all news